Norfloxacin

Norfloxacin, norfloxacin, 70458-96-7, Noroxin, Norfloxacine, Chibroxin, Baccidal, Sebercim, MK-366, Norfloxacino, Fulgram, Norfloxacinum, 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, AM-715, NFLX, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Utinor, DTXSID7037680, 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid, NSC-757250, N0F8P22L1P, CHEBI:100246, 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure, DTXCID5017680, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, MK366, MK0366, AM0715, MK 366, AM 0715, norfloxacina, Quinabic, 1-ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-ylquinoline-3-carboxylate, RefChem:57698, J01MA06, S01AE02, 274-614-4, Barazan, MFCD00079532, C16H18FN3O3, Lexinor, Zoroxin, MK-0366, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid, CHEMBL9, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid, MLS000069650, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid, NCGC00016916-01, NCGC00016916-09, SMR000058200, CAS-70458-96-7, Norfloxacine [INN-French], Norfloxacinum [INN-Latin], Norfloxacino [INN-Spanish], AM 715, Noflo, Norflo, MK 0366, 1-ethyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid, Noroxin (TN), CCRIS 6302, SR-01000000222, EINECS 274-614-4, BRN 0567897, UNII-N0F8P22L1P, Chibroxine, Chibroxol, Gonorcin, Nolicin, Noracin, Noraxin, Norocin, Noroxine, Norxacin, Uroxacin, Amicrobin, , Chibroxin, , Baccidal, , Esclebin, , Fortimax, , Barazan, , Espeden, , Fulgram, , Lexinor, , Norfloxacin CRS, Nalion, , HSDB 8029, Prestwick_633, Norfloxacin protomer I, Norfloxacin [USAN:USP:INN:BAN:JAN], Norfloxacin (Norxacin), Norfloxacin (Standard), Norfloxacin protomer II, Spectrum_001017, NORFLOXACIN [MI], Opera_ID_1423, Prestwick0_000221, Prestwick1_000221, Prestwick2_000221, Prestwick3_000221, Spectrum2_001017, Spectrum3_000524, Spectrum4_000453, Spectrum5_001154, NORFLOXACIN [INN], NORFLOXACIN [JAN], PEFLOXACINE_met009, NORFLOXACIN [USAN], Epitope ID:119068, NORFLOXACIN [VANDF], SCHEMBL3473, NORFLOXACIN [MART.], Oprea1_375152, BSPBio_000261, BSPBio_002107, KBioGR_000866, KBioSS_001497, NORFLOXACIN [USP-RS], NORFLOXACIN [WHO-DD], MLS006011446, BIDD:GT0725, DivK1c_000084, SPECTRUM1500440, SPBio_001173, SPBio_002182, BPBio1_000289, orb1309041, orb3025251, Norfloxacin (JP18/USP/INN), BCBcMAP01_000218, GTPL12408, HMS500E06, HY-B0132R, KBio1_000084, KBio2_001497, KBio2_004065, KBio2_006633, KBio3_001607, MSK5738, NORFLOXACIN [ORANGE BOOK], NINDS_000084, GLXC-20579, HMS1568N03, HMS1920B16, HMS2090F03, HMS2091J16, HMS2095N03, HMS2235G03, HMS3712N03, HMS5087E17, NORFLOXACIN [EP MONOGRAPH], NORFLOXACIN [USP IMPURITY], Pharmakon1600-01500440, ALBB-015911, HY-B0132, RKL10074, Tox21_110682, Tox21_113441, BBL005569, BDBM50045000, CCG-40235, EBC-04415, MSK5738-100M, NSC757250, s1509, SBB012542, STK177250, AKOS000417391, Norfloxacin for system suitability CRS, Norfloxacin, Pefloxacin EP Impurity A, Tox21_110682_1, AC-6855, AN26450, CS-1906, DB01059, KS-5007, Norfloxacin for peak identification CRS, NSC 757250, 1-ethyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, IDI1_000084, SMP1_000216, NCGC00016916-02, NCGC00016916-03, NCGC00016916-04, NCGC00016916-05, NCGC00016916-06, NCGC00016916-07, NCGC00016916-08, NCGC00016916-11, NCGC00016916-12, NCGC00021725-03, NCGC00021725-04, ST072202, SY051390, Norfloxacin 100 microg/mL in Acetonitrile, SBI-0051464.P002, N0817, Norfloxacin Solution in Methanol, 100ug/mL, NS00000224, EN300-06467, C06687, D00210, AB00052059-18, AB00052059-19, AB00052059_20, AB00052059_21, Norfloxacin, analytical standard, >=98% (TLC), Norfloxacin, VETRANAL(TM), analytical standard, F370848, Q417897, SR-01000000222-2, SR-01000000222-3, BRD-K11196887-001-05-5, BRD-K11196887-001-15-4, BRD-K11196887-001-20-4, BRD-K11196887-001-21-2, BRD-K11196887-001-22-0, Z56926638, Norfloxacin, British Pharmacopoeia (BP) Reference Standard, Norfloxacin, European Pharmacopoeia (EP) Reference Standard, 1-Ethyl-3-carboxy-6-fluoro-7-(piperazinyl-1)-quinolin-4(1H)-one, Norfloxacin, United States Pharmacopeia (USP) Reference Standard, Norfloxacin, Pharmaceutical Secondary Standard, Certified Reference Material, (NFLX)1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-6-fluoro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid, 1-ethyl-4-oxo-6-fluoro-7-(piperazinyl)-1,4-dihydro-quinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylicAcid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid #, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic Acid, 1-ethyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, 7-(1-Piperazinyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Norfloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard, Norfloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard, (norfloxacin)1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4,4a,8a-tetrahydro-quinoline-3-carboxylic acid (norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid (Norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid(1-norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid(Norfloxacin)